Related references
Note: Only part of the references are listed.Reduction in Neisseria meningitidis infection in Italy after Meningococcal C conjugate vaccine introduction: A time trend analysis of 1994-2012 series
Chiara de Waure et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Increased incidence of invasive meningococcal disease of serogroup C / clonal complex 11, Tuscany, Italy, 2015 to 2016
P. Stefanelli et al.
EUROSURVEILLANCE (2016)
Charlson comorbidity index as a predictor of in-hospital death in acute ischemic stroke among very old patients: a single-cohort perspective study
Lorenzo Falsetti et al.
NEUROLOGICAL SCIENCES (2016)
Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease
Philip S. Watson et al.
VACCINE (2016)
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
M. J. M. Bonten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
THE CLINICAL FEATURES AND LONG-TERM SEQUELAE OF INVASIVE MENINGOCOCCAL DISEASE IN CHILDREN
Chen Stein-Zamir et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?
Catherine Weil-Olivier et al.
VACCINE (2014)
Towards the 13-valent pneumococcal conjugate universal vaccination Effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013
Domenico Martinelli et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
US Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
Marie R. Griffin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
Rebecca A. Gladstone et al.
EXPERT REVIEW OF VACCINES (2012)
Progress and challenges in bacterial meningitis
Diederik van de Beek
LANCET (2012)
The changing and dynamic epidemiology of meningococcal disease
Scott A. Halperin et al.
VACCINE (2012)
The remaining challenges of pneumococcal disease in adults
E. Ludwig et al.
EUROPEAN RESPIRATORY REVIEW (2012)
Bacterial Meningitis in the United States, 1998-2007
Michael C. Thigpen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
Hope L. Johnson et al.
PLOS MEDICINE (2010)
Invasive Haemophilus influenzae Disease, Europe, 1996-2006
Shamez Ladhani et al.
EMERGING INFECTIOUS DISEASES (2010)
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
Caroline L. Trotter et al.
EXPERT REVIEW OF VACCINES (2009)
Risk factors for death in a cohort of patients with and without healthcare-associated infections in Finnish acute care hospitals
M. Kanerva et al.
JOURNAL OF HOSPITAL INFECTION (2008)
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae
Caroline L. Trotter et al.
VACCINE (2008)
Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines
Caroline L. Trotter et al.
FEMS MICROBIOLOGY REVIEWS (2007)
Community-acquired Haemophilus influenzae meningitis in adults
M. C. Brouwer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Medical progress: Meningococcal disease.
NE Rosenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries
M Kalin et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
